Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes

There has been an increasing number of approvals for targeted therapies and immunotherapies in oncology in the past decade. This has changed the treatment paradigm for many solid tumors and hematologic malignancies, and therefore the outcomes of patients with cancer. Advanced practitioners should be...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Donald C., Guinigundo, Andrew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190803/
https://www.ncbi.nlm.nih.gov/pubmed/37206906
http://dx.doi.org/10.6004/jadpro.2023.14.3.15
_version_ 1785043350827565056
author Moore, Donald C.
Guinigundo, Andrew S.
author_facet Moore, Donald C.
Guinigundo, Andrew S.
author_sort Moore, Donald C.
collection PubMed
description There has been an increasing number of approvals for targeted therapies and immunotherapies in oncology in the past decade. This has changed the treatment paradigm for many solid tumors and hematologic malignancies, and therefore the outcomes of patients with cancer. Advanced practitioners should be up to date with advances in cancer biomarker testing and its implications for the use of targeted therapy and immunotherapy to integrate this information into clinical decision-making.
format Online
Article
Text
id pubmed-10190803
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-101908032023-05-18 Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes Moore, Donald C. Guinigundo, Andrew S. J Adv Pract Oncol Review There has been an increasing number of approvals for targeted therapies and immunotherapies in oncology in the past decade. This has changed the treatment paradigm for many solid tumors and hematologic malignancies, and therefore the outcomes of patients with cancer. Advanced practitioners should be up to date with advances in cancer biomarker testing and its implications for the use of targeted therapy and immunotherapy to integrate this information into clinical decision-making. Harborside Press LLC 2023-04 2023-04-01 /pmc/articles/PMC10190803/ /pubmed/37206906 http://dx.doi.org/10.6004/jadpro.2023.14.3.15 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Moore, Donald C.
Guinigundo, Andrew S.
Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
title Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
title_full Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
title_fullStr Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
title_full_unstemmed Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
title_short Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
title_sort revolutionizing cancer treatment: harnessing the power of biomarkers to improve patient outcomes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190803/
https://www.ncbi.nlm.nih.gov/pubmed/37206906
http://dx.doi.org/10.6004/jadpro.2023.14.3.15
work_keys_str_mv AT mooredonaldc revolutionizingcancertreatmentharnessingthepowerofbiomarkerstoimprovepatientoutcomes
AT guinigundoandrews revolutionizingcancertreatmentharnessingthepowerofbiomarkerstoimprovepatientoutcomes

Ejemplares similares